|(30 Aug 2018)
Legal action against health care and pharmaceutical companies in federal courts has sharply increased over the last five years, and in particular since late 2017.
The latest available data from the federal courts on personal injury suits against health care and pharmaceutical companies show that levels of civil filings across the country remain elevated, although have dropped off from their peak in April 2018. During July 2018 there were 1,738 new lawsuits filed against health care and pharmaceutical companies. While there is variation in number of filings on a monthly basis, overall, civil filings against health care and pharmaceutical companies have increased by nearly three-fold (282 percent) since July 2013.
Louisiana's Eastern District and New Jersey alone comprise more than half of civil filings in months where civil filings sharply increase, including June 2016, and October 2017 - April 2018. Litigation peaked in April 2018 with 5,077 lawsuits filed nationwide. Prior to 2013, civil filings in these matters numbered less than 500 each month.
The two largest spikes in civil filings occurred in Oct-Dec 2017, and then again in April 2018. In both cases, the Eastern District of Louisiana and New Jersey accounted for the largest number of lawsuits, far outstripping any other federal districts. According to court records, litigation against pharmaceutical companies drove the increase in civil filings in Louisiana since 2016, while litigation against producers of talcum powder, especially Johnson & Johnson, was a key driver in the rise in New Jersey litigation in 2018.
For further details, see:
Each month, TRAC offers a report focused on one area of civil litigation in the U.S. district courts. In addition, subscribers to the TRACFed data service can generate custom reports by district, office, nature of suit or federal jurisdiction with data updated through July 2018. To start, go to:
If you want to be sure to receive notification whenever updated data become available, sign up at:
or follow us on Twitter @tracreports or like us on Facebook:
TRAC is self-supporting and depends on foundation grants, individual contributions and subscription fees for the funding needed to obtain, analyze and publish the data we collect on the activities of the US Federal government. To help support TRAC's ongoing efforts, go to: